The Houston Airport System announced a Memorandum of Understanding with Wisk Aero, a fully-owned subsidiary of Boeing. Photo via wisk.aero

A fleet of electric and autonomous air taxis is expected to take flight in Houston, thanks to a partnership between a California startup and the Houston Airport System.

HAS announced a Memorandum of Understanding with Wisk Aero, a fully-owned subsidiary of Boeing, which recently announced a similar partnership with the city of Sugar Land. For the next year, the company will identify vertiport infrastructure at Houston's three airports — George Bush Intercontinental Airport, William P. Hobby Airport, and Ellington Airport.

“During my time in the Texas senate, I voted for legislation supporting advanced air mobility. This public-private partnership marks a significant step forward for the City of Houston as we invest in innovative and sustainable modes of air transportation,” Houston Mayor John Whitmire says in a statement. “The collaboration underscores our commitment to pioneer advancements that will shape the future of urban mobility.”

Wisk will also develop Houston-area relationships and chart out flight paths for self-flying, electric vertical takeoff and landing (eVTOL) air taxis. The company's Generation 6 aircraft is autonomous, but a human supervisor remotely oversees every flight.

"Houston is at the forefront of aviation and aerospace innovation, so it’s only fitting that Houston Airports take the first steps to explore the next generation of air transportation,” says Jim Szczesniak, director of aviation for Houston Airports. “Our partnership with Wisk represents a bold step towards revolutionizing air mobility not just within our city, but across the entire Greater Houston region."

Earlier this year, Wisk partnered in a similar capacity with Sugar Land. The company and HAS will also work with the Federal Aviation Administration on this initiative.

“Our partnership with Houston Airports solidifies Wisk’s commitment to creating new and efficient ways to travel within the Greater Houston area and furthers our relationship with infrastructure and regulatory partners in the region," adds Brian Yutko, CEO at Wisk. “Connecting suburbs to Houston’s airports, business centers and prime tourist destinations through autonomous, sustainable air travel will create a new form of urban mobility and have tremendous economic and workforce impacts, supporting the growth of the Houston region.”

In addition to early infrastructure planning for maintenance and training facilities in Houston, the partnership means Houston Airports and Wisk will collaborate on integrating AAM into HAS's long-term plans.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

European spacecraft developer expands to Houston with U.S. business, new lab

houston hq

European aerospace manufacturer The Exploration Company has established its first U.S. entity and named Space City as its headquarters.

The company announced earlier this month that it has launched TEC Federal to support U.S. government customers and agencies, and to scale The Exploration Company's engineering operations in the country.

Mark Kirasich serves as president of TEC Federal. Kirasich most recently served as the senior director of human spaceflight at Blue Origin after a nearly 40-year career at NASA.

The Exploration Company is developing the reusable Nyx space vehicle. Nyx is designed to take off from any heavy launcher in the world. It will then dock at space stations, retrieve up to 3,000 kilograms of cargo, splash down and return the cargo to Earth. The company aims to make Nyx fully reusable for up to 10 missions, making it a more affordable and sustainable option for aerospace missions.

The Exploration Company completed a successful drop test of the spacecraft in May in the Mojave Desert. The company says Nyx is slated to perform its first flight demonstration in 2028.

In addition to launching the Houston business, The Exploration Company also opened its new Rapid Innovation Lab near Houston's NASA Johnson Space Center on Space Park Drive.

The Exploration Company opened its Rapid Innovation Lab earlier this month. Photo via LinkedIn

The Rapid Innovation Lab features a full-scale mockup of the future Nyx crew capsule as well as ongoing development and testing of the Nyx cargo capsule, according to the company.

The Exploration Company says the new lab will allow its engineers, designers, and operators to prototype and test crew interfaces. It will also support partnerships with NASA personnel and astronauts.

“Houston gives us direct access to the people and expertise that have built and operated human spaceflight systems for decades. We’re excited to invest and expand around that— engineers, operators, and astronauts working together and moving quickly towards building a crew capsule.” Hélène Huby, founder and CEO of The Exploration Company, said in a blog post.

According to The Houston Chronicle, The Exploration Company has about 30 employees in the Houston area.

The company was founded in 2021 by Huby, a French rocket scientist, and has raised more than $350 million in venture capital. It operates out of Germany, France, Luxembourg, Spain and Italy, with offices in the U.S. and the United Arab Emirates. It is also developing a reusable, high-thrust rocket engine known as Storm.

UH lands $4M NIH grant to study early signs of autoimmune disease

NIH funding

The University of Houston recently received a $4 million National Institutes of Health grant to support a 10-year longitudinal study to identify the earliest biological markers of autoimmune disease.

Led by Chandra Mohan, the Hugh Roy and Lillie Cranz Cullen Endowed Professor of Biomedical Engineering, the study aims to examine what causes Systemic Autoimmune Rheumatic Diseases (SARDs) and to identify targets for future treatments. The study will be carried out in collaboration with Dr. Karen Costenbader at Harvard Medical School, Boston.

SARDs include conditions like rheumatoid arthritis, systemic lupus erythematosus, Sjögren’s syndrome and systemic sclerosis—all are considered chronic diseases currently without a cure. Autoimmune diseases affect over 30 million people globally, according to UH.

SARDs occur when the body’s immune system attacks healthy, non-threatening tissues and organs. According to UH, in these diseases, the body often attacks nuclear antigens, creating anti-nuclear autoantibodies, which can be early detection signs for SARDs in more than 50 percent of patients, Mohan says.

Researchers will study blood samples and environmental exposure over the 10 years to better understand anti-nuclear autoantibodies.

“Collectively, these studies will help identify the genetic, environmental and cellular factors that are operative at the two steps of SARD development, namely the emergence of anti-nuclear autoantibodies and disease onset,” Mohan said in a news release. “ More importantly, these studies will highlight functional molecular pathways and mechanisms that may be operative at each step."

Mohan predicts that looking at SARDs’ shared characteristics, rather than each disease individually, could help identify more treatment methods.

“Individual SARDs have been examined in silos without an attempt to discern shared underlying features at the molecular level,” he added in the release. “Current understanding of the initial (and likely shared) origins of SARDs is only rudimentary but urgently needed to develop means for prevention and treatment.”

Earlier this year, UH also received an $11 million NIH grant to conduct a first-of-its-kind study of early language development in children ages 18 to 24 months. Read more here.